1. Home
  2. Vol 56, No 3 (2024)
  3. Salsabil

Hypertonic Dextrose Prolotherapy Injection in Grade IV Knee Osteoarthritis with Obesity: A Case Report

Juwita Raudlatul Salsabil, Rita Vivera Pane, Hasan Hasan, Aufar Zimamuz Zaman Al Hajiri

Abstract


The main complaint in knee osteoarthritis (KOA) is knee pain and limited range of motion (ROM) which affects the patient's quality of life. Dextrose prolotherapy successfully reduced pain and enhanced functional status and quality of life in chronic knee pain, which is classified as KOA grade II or III by the Kellgren-Lawrence classification. We present a case of grade IV KOA with co-morbid obesity who refused surgical management but got dextrose prolotherapy instead. She received prolotherapy for the right knee 5 times with a gap of 4 weeks between treatments. Western Ontario and McMaster Universities Osteoarthritis (WOMAC score), Numerical Rating Scale (NRS), knee ROM, Barthel index, count test, and Timed Up and Go Test (TUG) were evaluated 1 day after each treatment and compared to each post-injection score. This patient is also comorbid of grade II obesity which is associated with mechanical loads on the knee joint causing inflammation and progression of KOA. After 5 months of prolotherapy treatment, strengthened quadricep muscle exercising and static cycle endurance exercising, she improved her pain, WOMAC score, and cardiorespiratory function. Hypertonic dextrose prolotherapy (HDP) is one of the choices for interventional therapy of its advantages, inexpensive, easily conducted, safe with minimal or even no recorded complications, and long-term efficacy even for grade IV of KOA like this patient.


Keywords


osteoarthritis; obesity; hypertonic dextrose prolotherapy

References


Waluyo Y, Bukhari A, Adnan E, et al. Association between cartilage biomarker level and functional outcome in knee osteoarthritis patients receiving dextrose prolotherapy: a cross-sectional study. Bali Med J. 2022;11(3):1151–6.

Cortez VS, Moraes WA, Taba JV, Condi A, Suzuki MO, Nascimento FS do, et al. Comparing dextrose prolotherapy with other substances in knee osteoarthritis pain relief: A systematic review. Vol. 77, Clinics. Clinics (Sao Paulo); 2022.

Topol GA, Pestalardo IG, Reeves KD, et al. Dextrose prolotherapy for symptomatic grade IV knee osteoarthritis: A pilot study of early and longer-term analgesia and pain-specific cytokine concentrations. Clin Pract. 2022;12(6):926.

Wee TC, Neo EJR, Tan YL. Dextrose prolotherapy in knee osteoarthritis: A systematic review and meta-analysis. Journal of Clinical Orthopaedics and Trauma. J Clin Orthop Trauma. 2021;19:108–17.

Sananta P, Zahrah VT, Widasmara D, Fuzianingsih EN. Association between diabetes mellitus, hypertension, and knee osteoarthritis in secondary referral hospitals in Indonesia with retrospective cross-sectional study. Ann Med Surg. 2022;80.

Cui A, Li H, Wang D, Zhong J, Chen Y, Lu H. Global, regional prevalence, incidence and risk factors of knee osteoarthritis in population-based studies. E Clinical Medicine. 2020;29–30.

Kloppenburg M, Berenbaum F. Osteoarthritis year in review 2019: epidemiology and therapy. Osteoarthr Cartil. 2020;28(3):242–8.

Grässel S, Muschter D. Recent advances in the treatment of osteoarthritis. F1000 Research. 2020;9.

Sit RWS, Wu RWK, Rabago D, et al. Efficacy of intra-articular hypertonic dextrose (Prolotherapy) for knee osteoarthritis: A randomized controlled trial. Ann Fam Med. 2020;18(3):235–42.

Sert AT, Sen EI, Esmaeilzadeh S, Ozcan E. The effects of Dextrose prolotherapy in symptomatic knee osteoarthritis: A randomized controlled study. J Altern Complement Med. 2020;26(5):409–17.

Billesberger LM, Fisher KM, Qadri YJ, Boortz-Marx RL. Procedural treatments for knee osteoarthritis: A review of current injectable therapies. Pain Research and Management. Hindawi Limited. 2020;2020.

Arias-Vázquez PI, Tovilla-Zárate CA, Castillo-Avila RG, et al. Hypertonic dextrose prolotherapy, an alternative to intra-articular injections with hyaluronic acid in the treatment of knee osteoarthritis: Systematic review and meta-analysis. Am J Phys Med Rehabil. 2022;101(9):816–25.

Pane RV, Setiyaningsih R, Widodo G, Al Hajiri AZZ, Salsabil JR. Femoral cartilage thickness in knee osteoarthritis patients and healthy adults: An ultrasound measurement comparison. Sci World J. 2023;2023:1–4.

Zhao AT, Caballero CJ, Nguyen LT, Vienne HC, Lee C, Kaye AD. A comprehensive update of prolotherapy in the management of osteoarthritis of the knee. Orthop Rev (Pavia). 2022;14(4).

Poliwoda S, Noor N, Mousa B, et al. A comprehensive review of intraarticular knee injection therapy, geniculate injections, and peripheral nerve stimulation for knee pain in clinical practice. Orthop Rev (Pavia). 2022;14(4).

Rabago D, Kansariwala I, Marshall D, Nourani B, Stiffler-Joachim M, Heiderscheit B. Dextrose prolotherapy for symptomatic knee osteoarthritis: Feasibility, acceptability, and patient-oriented outcomes in a pilot-level quality improvement project. J Altern Complement Med. 2019;25(4):406–12.

Misra D, Fielding RA, Felson DT, et al. Risk of knee osteoarthritis with obesity, sarcopenic obesity, and sarcopenia. Arthritis Rheumatol. 2019;71(2):232–7.

Caiado VS, Santos ACG, Moreira-Marconi E, et al. Effects of physical exercises alone on the functional capacity of individuals with obesity and knee osteoarthritis: A systematic review. Biology (Basel). 2022;11.

Pane RV, Aisyah, Ariani H, Isparnadi E, Al Hajiri AZZ, Setiawan A. Ultrasound assessment of femoral cartilage thickness among healthy Indonesian adults. Bali Med J. 2022;11(3):2013–6.

Panunzi S, Maltese S, De Gaetano A, Capristo E, Bornstein SR, Mingrone G. Comparative efficacy of different weight loss treatments on knee osteoarthritis: A network meta-analysis. Obesity Reviews. Obes Rev. 2021;22.

Dolatkhah N, Toopchizadeh V, Barmaki S, et al. The effect of an anti-inflammatory in comparison with a low caloric diet on physical and mental health in overweight and obese women with knee osteoarthritis: a randomized clinical trial. Eur J Nutr. 2022.

Chen YW, Lin YN, Chen HC, Liou TH, Liao C De, Huang SW. Effectiveness, compliance, and safety of Dextrose prolotherapy for knee osteoarthritis: A meta-analysis and metaregression of randomized controlled trials. Clin Rehabil. 2022;36(6):740–52.


Full Text: PDF

Refbacks

  • There are currently no refbacks.